APA aipamena

Horne, K. C., Howden, B. P., Grabsch, E. A., Graham, M., Ward, P. B., Xie, S., . . . Grayson, M. L. (2009). Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA. American Society for Microbiology (ASM).

Chicago Style aipamena

Horne, K. C., B. P. Howden, E. A. Grabsch, M. Graham, P. B. Ward, S. Xie, B. C. Mayall, P. D. R. Johnson, and M. L. Grayson. Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus Aureus (MRSA) and Vancomycin-Susceptible MRSA. American Society for Microbiology (ASM), 2009.

MLA aipamena

Horne, K. C., et al. Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus Aureus (MRSA) and Vancomycin-Susceptible MRSA. American Society for Microbiology (ASM), 2009.